Drug Trial Radar · NCT02720692
Evaluation of N1539 Following Major Surgery
Last checked: Nov 19, 2026Latest source record: Jun 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
722
Actual
Start
Mar 2016
Primary completion
Mar 2017
Study completion May 2017
Sponsor
- Lead sponsor
- Baudax BioIndustry
- Sponsor type
- Industry
- First posted
- Mar 28, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the safety and tolerability of N1539 in a variety of post-surgical conditions.
Conditions
- Pain, Post-operative
Interventions
N1539Drug
Intravenous PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects With Adverse EventsTime frame: 28 Days
Locations
32 sites in 4 countries. Site status is shown where the registry gives one.
Site not named
Florence, Alabama
Site not named
Montgomery, Alabama
Site not named
Sheffield, Alabama
Site not named
Gilbert, Arizona
Site not named
Phoenix, Arizona
Site not named
Anaheim, California
Site not named
Bakersfield, California
Site not named
Miami, Florida
Site not named
Tamarac, Florida
Site not named
Tampa, Florida
Site not named
Chicago, Illinois
Site not named
Great Falls, Montana
Site not named
Cleveland, Ohio
Site not named
Columbus, Ohio
Site not named
Tyrone, Pennsylvania
Site not named
Hendersonville, Tennessee
Site not named
Houston, Texas
Site not named
Houston, Texas
Site not named
San Antonio, Texas
Site not named
Salt Lake City, Utah
Site not named
Chermside, Queensland, Australia
Site not named
Kippa-Ring, Queensland, Australia
Site not named
Southport, Queensland, Australia
Site not named
Richmond, Victoria, Australia
Site not named
Halifax, Nova Scotia, Canada
Site not named
Kingston, Ontario, Canada
Site not named
Toronto, Ontario, Canada
Site not named
Montreal, Quebec, Canada
Site not named
Montreal, Quebec, Canada
Site not named
Auckland, New Zealand
Site not named
Christchurch, New Zealand
Site not named
Hamilton, New Zealand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.